Moreover, a transcriptional axis of FOXP3-BRCA1-miR-155 in breast cancer cells has been reported, suggesting that plasma miR-155 may serve as a non-invasive biomarker for the detection of early stage breast cancer [17]. This evidence concerns the gene BRCA1 and breast carcinoma.